About Lancor Scientific
Lancor Scientific is a company based in London (United Kingdom) founded in 2018. It operates as a B2C. Lancor Scientific operates in a competitive market with competitors including MediChecks, WomenWise, Abingdon Simply Test, GetLabTest and Project Tide, among others.
- Headquarter London, United Kingdom
- SectorsHealthcare
- Website lancorscientific.com
- Social X
Competitors of Lancor Scientific
Lancor Scientific operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediChecks, WomenWise, Abingdon Simply Test, GetLabTest and Project Tide, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medichecks.com | 2002 | – | – | 49 | Online platform for home-to-lab Dx tests | |
| womenwise.health | 2021 | London, United Kingdom | – | – | Delivers personalized support services for women experiencing menopause. | |
| abingdonsimplytest.com | 2022 | York, United Kingdom | – | – | Provides online self-tests for health monitoring, fertility, and disease detection. | |
| getlabtest.com | 2022 | Halesowen, United Kingdom | – | – | Provides online health tests, AI analysis, and personalized medical consultations. | |
| projecttide.co.uk | 2015 | Oxford, United Kingdom | – | – | Delivers a comprehensive app for tuberculosis diagnostics and solutions. | |
| purevitalityhealth.co.uk | 2019 | Leeds, United Kingdom | – | – | Offers advanced health screenings and hydrogen-rich water for vitality evaluation. | |
| reddrop.co.uk | 2017 | Portsmouth, United Kingdom | – | – | Offers health screening, blood tests, and digital healthcare solutions. | |
| shemed.com | 2024 | London, United Kingdom | $49.9M | – | Provides telemedicine services and diagnostic test kits for consumer health needs. |
Detailed competitors of Lancor Scientific
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lancor Scientific
Complete news archive for Lancor Scientific
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Lancor Scientific
10 companies that operate in the same segment as Lancor Scientific (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lancor Scientific
Lancor Scientific was founded in 2018.
Lancor Scientific is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Lancor Scientific offers an online platform for booking cancer screening tests through providing healthcare solutions, offering diagnostic solutions, cancer screening, and online booking. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Lancor Scientific's top competitors include MediChecks, WomenWise and Abingdon Simply Test.